Bio-Rad Laboratories 

$297.43
105
+$3.73+1.27% Monday 21:00

統計

當日最高
297.91
當日最低
290.58
52週高點
358.4
52週低點
211.43
成交量
129,948
平均成交量
189,024
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

財報

12Feb預期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
1.16
1.81
2.46
3.11
預期EPS
2.714682
實際EPS
不適用

財務

-71.86%利潤率
未盈利
2019
2020
2021
2022
2023
2024
5.13B營收
-3.69B淨利

分析師評級

$357.50平均目標價
最高預估為 375.00。
來自過去6個月內的 2 則評分。這不是投資建議。
買入
50%
持有
50%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BIO 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
執行長
Mr. Norman D. Schwartz
員工
7700
國家
US
ISIN
US0905722072

上市

0 Comments

分享你的想法

FAQ

Bio-Rad Laboratories 今天的股價是多少?
BIO 目前價格為 $297.43 USD,過去 24 小時上漲了 +1.27%。在圖表上更密切關注 Bio-Rad Laboratories 股價表現。
Bio-Rad Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Bio-Rad Laboratories 的股票以代號 BIO 進行交易。
Bio-Rad Laboratories 的股價在上漲嗎?
BIO 股票較上週下跌 -0.09%,本月下跌 -2.57%,過去一年 Bio-Rad Laboratories 下跌 -15.77%。
Bio-Rad Laboratories 下一次財報日期是什麼時候?
Bio-Rad Laboratories 將於 February 12, 2026 公布下一次財報。
Bio-Rad Laboratories 上一季度的財報如何?
BIO 上一季度的財報為每股 2.26 USD,預估為 1.95 USD,帶來 +15.66% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Bio-Rad Laboratories 去年的營收是多少?
Bio-Rad Laboratories 去年的營收為 5.13BUSD。
Bio-Rad Laboratories 去年的淨利是多少?
BIO 去年的淨收益為 -3.69BUSD。
Bio-Rad Laboratories 有多少名員工?
截至 February 03, 2026,公司共有 7,700 名員工。
Bio-Rad Laboratories 位於哪個產業?
Bio-Rad Laboratories從事於Health Care產業。
Bio-Rad Laboratories 何時完成拆股?
Bio-Rad Laboratories 上次拆股發生於 March 08, 2002,比例為 2:1。
Bio-Rad Laboratories 的總部在哪裡?
Bio-Rad Laboratories 的總部位於 US 的 Hercules。